3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020The Motley Fool • 09/04/20
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval24/7 Wall Street • 09/02/20
How You Might Own a Stake in Moderna's Coronavirus Vaccine Without Even Knowing ItThe Motley Fool • 09/02/20
FDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head SaysThe Motley Fool • 08/31/20
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20
Moderna Confirms Discussions with the Ministry of Health, Labour and Welfare to Supply Japan with 40 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)Business Wire • 08/28/20